Axsome Therapeutics (AXSM) Prepaid Assets (2015 - 2026)
Axsome Therapeutics' (AXSM) quarterly Prepaid Assets came in at $23.5 million in Q1 2026, up 46.95% year-on-year from $16.0 million in Q1 2025, and up 72.32% quarter-over-quarter from $13.7 million in Q4 2025.
Axsome Therapeutics (AXSM) Prepaid Assets (2015 - 2026) Analysis & Trends
Axsome Therapeutics has disclosed Prepaid Assets across 12 years of filings, most recently posting $23.5 million for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $23.5 million, up 46.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $23.5 million (up 46.95% YoY), and the FY2025 annual result was $13.7 million, up 13.97% from the prior year.
- Prepaid Assets came in at $23.5 million for Q1 2026 at Axsome Therapeutics, up from $13.7 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $23.5 million in Q1 2026 to a low of $2.1 million in Q1 2022.
- The 5-year median for Prepaid Assets is $11.8 million (2024), against an average of $10.4 million.
- Across the five-year window, Prepaid Assets soared 6040.97% in 2022 and rose 13.97% in 2025, its largest moves.
- Axsome Therapeutics' Prepaid Assets stood at $2.8 million in 2022, then surged by 191.8% to $8.1 million in 2023, then soared by 47.6% to $12.0 million in 2024, then climbed by 13.97% to $13.7 million in 2025, then jumped by 72.32% to $23.5 million in 2026.
- The last three Prepaid Assets figures came in at $23.5 million (Q1 2026), $13.7 million (Q4 2025), and $19.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Axsome Therapeutics | 12.84 Bn | 12.54 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.52 Mn |
| Dec 31, 2025 | 13.65 Mn |
| Sep 30, 2025 | 19.79 Mn |
| Jun 30, 2025 | 16.34 Mn |
| Mar 31, 2025 | 16.01 Mn |
| Dec 31, 2024 | 11.98 Mn |
| Sep 30, 2024 | 13.41 Mn |
| Jun 30, 2024 | 11.81 Mn |
| Mar 31, 2024 | 12.03 Mn |
| Dec 31, 2023 | 8.12 Mn |
| Sep 30, 2023 | 6.80 Mn |
| Jun 30, 2023 | 5.91 Mn |
| Mar 31, 2023 | 5.20 Mn |
| Dec 31, 2022 | 2.78 Mn |
| Sep 30, 2022 | 2.46 Mn |
| Jun 30, 2022 | 4.09 Mn |
| Mar 31, 2022 | 2.12 Mn |
| Dec 31, 2021 | 45,286.00 |
| Sep 30, 2021 | 401,302.00 |
| Jun 30, 2021 | 435,804.00 |